Growth Metrics

Novavax (NVAX) Notes Payables (2016 - 2022)

Historic Notes Payables for Novavax (NVAX) over the last 9 years, with Q4 2022 value amounting to $324.9 million.

  • Novavax's Notes Payables changed N/A to $324.9 million in Q4 2022 from the same period last year, while for Dec 2022 it was $324.9 million, marking a year-over-year change of. This contributed to the annual value of $324.9 million for FY2022, which is N/A changed from last year.
  • According to the latest figures from Q4 2022, Novavax's Notes Payables is $324.9 million.
  • Novavax's 5-year Notes Payables high stood at $324.9 million for Q4 2022, and its period low was $323.8 million during Q1 2022.